Skip to content

Decompressive craniectomy for mass effect in severe head injury

Prospective Randomized Evaluation of therapeutic decompressive Craniectomy In Severe traumatic brain injury with mass lesions (PRECIS)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN20139421
Enrollment
336
Registered
2015-05-20
Start date
2015-06-08
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe traumatic brain injury with mass lesions Injury, Occupational Diseases, Poisoning

Interventions

Once the eligible patient signs consent and confirms randomization, the interventions commence. Participants will be randomly allocated to either prophylactic DC group or therapeutic DC group. During

Sponsors

West China Hospital of Sichuan University (P. R. China)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age between 15 and 65 years old 2. Glasgow Coma Scale (GCS) = 8 3. Marshall Classification VI, presence of high- or mix-density lesion = 25 ml (contusion, intraparenchymal and subdural hematoma) 4. Neurological status progressive deterioration within 24 h after injury (GCS motor score fall by 2 points or blunt pupillary response)

Exclusion criteria

Exclusion criteria: 1. Bilateral mydriasis of critically endangered status 2. Cerebellum contusion 3. Penetrating brain injury 4. Serious extracranial injury with unstable vital signs 5. Beyond 24 h after injury 6. Known cognitive or neurological impairment 7. Breastfeeding or pregnancy 8. Definite surgical contraindications

Design outcomes

Primary

MeasureTime frame
Favorable outcome at 12 months after randomization, measured by Extended Glasgow outcome scale (5–8)

Secondary

MeasureTime frame
1. Quality of life (EQ-5D) at 6 and 12 months after randomization 2. Mortality at 6 months and 12 months after randomization 3. Incidence of re-operation with salvage DC in craniotomy patients of therapeutic DC group at one month after randomization 4. ICP and CPP control during 1 week after randomization (intraoperative and postoperative) 5. Complications at 1 month, 6 months and 12 months

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026